Clinical Utility of Growth Factors and Platelet-Rich Plasma in Tissue Regeneration: A Review

Review

Clinical Utility of Growth Factors and Platelet-Rich Plasma in Tissue Regeneration: A Review

Keywords

July 2014

ISSN 1044-7946

Index WOUNDS. 2014;26(7):207-213.

Abstract

Introduction. Many elements are involved in the regenerative process of injured tissues, such as cytokines and growth factors. Growth factors contained in platelets represent an important physiological mixture of factors that may be involved in the healing process. Method. A literature review on the role played by certain biomolecules, such as growth factors and platelet-rich plasma (PRP), in the healing of different tissues and on their therapeutic use to promote this process was undertaken. Results. In this review, the authors found a great number of studies that showed the effect of growth factors and PRP in the regeneration of different tissues. Platelet-rich plasma is a natural source of growth factors and this has been successfully used in different clinical situations such as dentistry, plastic surgery, trauma and orthopedics, ocular surgery, gastroenterology, or skin ulcers. However, standardized protocol for its preparation and application has yet to be established. Conclusion. The authors recommend further research is required to establish the exact role of PRP in the treatment of tissue regeneration and to develop a standardized protocol for its use.

Introduction

Wound healing is a complex process mediated by interacting molecular signals involving mediators and cellular events. It is followed by mesenchymal cell recruitment, proliferation, and extracellular matrix generation, which allows for scar formation. These events are mediated and modulated by interacting molecular signals, primarily cytokines, and growth factors (GFs) that stimulate and modulate the main cellular activities that underscore the healing process.^1,2 Several studies have demonstrated that chronic wounds may, in some cases, lack GFs due to decreased production, decreased release, trapping, excess degeneration, or an association of these mechanisms.^3,4

Autologous platelets have been shown to promote tissue repair in several clinical situations as a source of healing factors. To regenerate an injured tissue, it is necessary to understand the participation of individual cell types and the role of soluble factors that contribute to the extrinsic and intrinsic healing properties of tissue. It is reported that several GFs play a key role in initiating and sustaining the different phases of tissue repair. Platelet alpha-granules are rich in GFs such as platelet-derived growth factor (PDGF), transforming growth factor-β (TGF-β), or vascular endothelial growth factor (VEGF). These factors play an important role in all phases of healing of the tissue by recruiting mesenchymal cells and also during the synthesis of the extracellular matrix. The topical application of platelet gel or platelet-rich plasma (PRP) provides exogenous GFs in situ.^1,2 Therefore, PRP is a tool that contributes toward the release of GFs to the wound area, which in turn makes it useful in promoting the functional recovery of physiological tissue repair.^5,6

The objective of this study was to review published reports on the role of GFs in tissue regeneration, focusing on PRP, a natural source of GFs.

Methods

A search of studies published between 2001 and 2012 reporting on the usefulness of GFs and PRP for the treatment of different wounds, using the MEDLINE, EMBASE, and Cochrane Library databases with the key words tissue regeneration, wound healing, growth factor, and platelet-rich plasma, was conducted. Titles and abstracts identified by the literature searches were read and reviewed. Those not appearing to meet key words were excluded and the others were reviewed in full.

Growth Factors

Growth factors are polypeptides produced by the tissue on which they act. They regulate differentiation, proliferation, migration, and metabolism in target cells, regulating the synthesis of specific adhesion molecules that control cell-cell and cell-substrate interactions. Each GF can have either one or several essential functions for a specific cell, depending on the particular circumstances of the cell environment. Certain GFs, sometimes secreted by the cell, interact with other cells through their corresponding receptor, which transmits a signal to the cells stimulating them to produce proteins in the medium.⁷

The most widely studied GFs in relation to tissue proliferation and repair include: bone morphogenetic proteins (BMPs) (eg, BMP-1, BMP-2, and BMP-3); PDGF; insulin-like growth factor (IGFs) (eg, IGF-I and IGF-II); TGFs, especially TGF-β; fibroblast growth factors (FGFs) (ie, acid-FGF and basic-FGF); granulocyte macrophage colony stimulating factor; epidermal growth factor; and VEGF. An important role in repair processes, specifically in the inflammation stages, is also played by cytokines produced by white blood cells, including the interleukins (ILs) IL-1, IL-3, IL-6, and IL-8. All of these GFs and cytokines act to a greater or lesser extent during the different stages of wound healing (ie, tissue necrosis resolution, cell regeneration, cell proliferation and migration, extracellular matrix synthesis, epithelization, and remodeling).^6-10Table 1 summarizes the functions of the main GFs in relation to different healing processes.

Platelet-Rich Plasma

Platelets play an important role in the regenerative process of a wound by releasing an important number of mitogenic and inflammatory substances¹¹; hence, they represent a natural source of GFs. They contain 3 large storage compartments: alpha granules, dense granules, and lysosomes.¹² All of these secretory granules contain GFs, proteins for coagulation, cell adhesion molecules, activation molecules, cytokines, integrins, and inflammatory molecules, among others, with most of these molecules being localized in alpha granules.¹³

When a wound is made, platelets initiate the hemostatic process by creating a complex network to plug vessels. At this point, platelets change their structure from a soft circular shape to a spherical shape and develop pseudopodia. This promotes their aggregation and adherence by redistributing receptors for their subsequent activation and degranulation,¹⁴ which ruptures their molecule-loaded granules and releases GFs into the medium to regulate the repair of damaged tissues.¹⁵ Peripheral blood can be centrifuged to obtain PRP, a fraction of plasma with a high concentration of platelets (5-fold higher than baseline) and hence with a high concentration of biomolecules with regenerative potential.¹⁶ Although PRP and plasma rich in GFs are used interchangeably by clinicians, they are different concepts. The PRGF is the fraction obtained from PRP by activation with calcium chloride.¹⁷

Platelet-rich plasma is used for tissue regeneration in different clinical settings and offers several advantages since it is neither toxic nor immunoreactive and can be readily obtained, inexpensively, from the blood of the patients themselves. Various studies have been published on the preparation and utilization of PRP for wound-healing, with controversial results.^18-22 Marx et al²³ reported the combination of PRP with a mixture containing 10% calcium chloride and bovine thrombin favored jaw reconstruction. The utilization of PRP has yielded satisfactory outcomes in dentistry and maxillofacial surgery,²⁴ plastic surgery,²⁵ trauma and orthopedic surgery,²⁶ tendon and ligament repair,²⁷ and ocular repair.²⁸

Clinical Application

The clinical utilization of PRP is highly varied, and new applications are constantly being reported for conditions in which more effective or rapid healing is required.

Dentistry. Periodontal surgery and dentistry are probably the fields in which most research has been conducted and which have obtained the most positive outcomes related to PRP. Autologous platelet gel was first used in oral and maxillofacial surgery in a patient by Whitman et al²⁹ as a co-adjuvant in the insertion of titanium implants. These authors concluded that the application of autologous platelet gel provided consolidation of the bone fragments and increased adherence of mucogingival flap. Autologous PRP subsequently proved useful in the reconstruction of jaw defects, with the finding that the GFs in platelets (eg, PDGF and TGF-β) accelerates bone formation when absorbed by bone grafts.²³ Numerous animal studies have demonstrated the benefits of using GFs and autologous plasma in oral cavity tissue regeneration.^30-32

The application of PRP after tooth extraction has proven beneficial for preventing alveolar osteitis and improving hemostasis as described by Mancuso et al³³ in a clinical study with 117 patients treated with PRGF after oral surgery. The results showed that the rate of alveolar osteitis was lower (3.4%) in bony sites treated with PRGF than sites not treated with PRGF(12.8%). The PRGF-treated sites also showed better hemostasis at the time of discharge and objectively faster soft tissue flap healing. Its use when treating post-extraction bone defects resulted in greater buccolingual and buccopalatal bone width, higher bone density, and greater tissue coverage in comparison to non-PRP-treated defects.²⁴ In another case report, the authors treated intrabone defects by adding PRP to a bone allograft in guided tissue regeneration and reported significant improvements in clinical insertion and bone filling.³⁴ In summary, PRP has shown promise in numerous studies as part of a simple and safe therapeutic approach in oral and maxillofacial surgery.^35-38

In an in vitro study, García-Martínez et al³⁹ showed the treatment of osteoblasts with PRP increased cell proliferation in the short term (15 days), and suggested the cell proliferation capacity diminished in the long term (30 days) because of cell exhaustion. The treatment with PRP also modified antigenic phenotype profile of cultured human osteoblasts by the expression of CD54, CD80, CD86, and HLA-DR antigens. The authors concluded that PRP treatment may accelerate bone neoplasia.

Plastic Surgery. Perhaps the most convincing evidence of the healing capacity of PRP has come from the field of plastic surgery. In a review on applications of platelet gel in facial plastic surgery, Bhanot and Alex⁴⁰ reported that autologous PRP is especially useful for plastic and repair surgery of soft tissues, in which the positive effects of GFs are especially marked. In a study of 14 patients with soft tissue loss caused by recent trauma or chronic pathologies and treated by application of autologous fibrin-platelet glue and platelet gel, Valbonesi et al⁴¹ reported that besides accelerating healing, PRP reduces the risk of infection and length of hospital stay, with a corresponding saving in health costs. Furthermore, Man et al⁴² stated that PRP has also proven effective to arrest capillary bleeding in flap surgery after observing that the application of autologous platelet gel in 20 patients undergoing cosmetic surgery was effective in achieving and maintaining hemostasis during surgical procedures.

Trauma and orthopedics. The application of PRP in trauma and orthopedic surgery remains highly controversial, despite numerous studies. Evidence remains sketchy on the biological diversity and on the platelet concentration required to achieve an accelerated response in bone. In some studies on bone grafts, PRP did not appear to increase bone formation.^43-45 While this is consistent with a report in a canine model,⁴⁶in vitro studies showed that PDGFs stimulate the proliferation of human trabecular bone-forming cells.⁴⁷ Importantly, Graziani et al⁴⁸ reported that the effectiveness of PRP on the proliferative capacity of osteoblasts and fibroblasts in vitro depends on the specific concentrations used.

Recent in vitro research into the effects of PRP and its molecular components on cell proliferation and human macrophage migration revealed an inhibition of such migration.⁴⁹ It showed a negative effect on healing, but positive stimulatory effects on osteoblasts, fibroblasts, and other cells. Platelet-rich plasma was found to be useful in human tendon and ligament repair by significantly increasing the proliferation of human tendinous cells and stimulating angiogenic factors, (eg, VEGF and hepatocyte-derived growth factor [HGF]).^26,50 In knee surgery, autologous PRP injection facilitated anterior cruciate ligament reconstruction and enhanced re-anchorage of chondral fragments of > 2 cm by arthroscopy, obtaining complete and accelerated healing with a good functional outcome.^5,51 Platelet-rich plasma injection in the common extensor tendon after suturing was also reported to aid in fiber reconstruction and relieve pain by different clinical assays.^27,52

Ocular Surgery. Platelet-rich plasma, which has only been recently introduced into ocular surgery, has been reported to increase cell proliferation in wounds to the retina, improving outcomes in both in vitro and in vivo studies.^28,53 Among other developments, this approach has also been used for peripheral nerve regeneration in rat models, obtaining highly favorable results from the application of platelet gel on nerve sutures.⁵⁴

Gastroenterology. Studies have been conducted on the treatment of gastric ulcers in rats, reporting promising data on ulcer healing after an oral dose of human PRP.⁵⁵

Skin Ulcers. Atri et al⁵⁶ claimed that the use of autologous PRP improved the formation of granulation tissue in skin ulcer healing. Platelet-derived wound-healing factors began to be used in chronic leg ulcers with high collagen content and was found to stimulate vascularization and enhance connective tissue formation.^57,58 The usefulness of PRP in pressure ulcer (PU) treatment remains under debate. Some authors concluded that the topical application of platelet lysates on ulcers has no effect on healing,⁵⁹ whereas others found a higher percentage of healed surfaces in PUs and other skin ulcers treated with PRP.⁶⁰ A platelet gel formed by a mixture of platelet concentrate and activated cryoprecipitate in the presence of calcium chlorides proved useful in treating a chronic ulcer on the foot of a diabetic patient, avoiding amputation.⁶¹

A study on venous leg ulcers demonstrated an increased expression of certain integrins after PDGF application, enhancing angiogenesis at sites of granulation tissue formation and favoring the construction of new venous networks.⁶² Recently, Ramos-Torrecillas et al⁶³ suggested that PRP is an inexpensive and easily applied treatment for PUs, making this is an alternative to traditional treatments.

Discussion

Encouraging outcomes, including tissue regeneration, have been obtained with PRP therapy in multiple clinical settings.^2,57 However, its clinical applications have varied widely, and since the GFs participate in different physiological responses of the organism and tissues,⁶⁴ PRP are a GF-rich source of general, rather than specific, usefulness to date. Furthermore, no common protocol has been developed for its preparation and application in regenerative therapy, especially in the treatment of ulcers, where the benefits of its topical application on ulcers remain controversial.^60,61 In this case, 2 factors must be considered: the heterogeneity of ulcers (eg, vascular, pressure, diabetic) and the variety of GFs present in PRP. Therefore, the response to treatment may be expected to vary according to differences in ulcer characteristics and growth factor content in plasma. Further research is required to establish the role of PRP in the treatment of tissue regeneration and to develop a standardized protocol for its preparation and application.

Conclusion

There is wide scientific evidence on the positive role of PRP in tissue regeneration and wound healing. Also, a major advantage of autologous PRP in the clinical setting is that it has no adverse effects. The authors recommend further research is required to establish the exact role of PRP in the treatment of tissue regeneration and to develop a standardized protocol for its use.

Acknowledgments

Affiliations: The authors are from the Department of Nursing, Faculty of Health Sciences, University of Granada, Granada, Spain.

Address correspondence to:
Concepción Ruiz, PhD
Department of Nursing
Faculty of Health Sciences
University of Granada
Avda. Madrid s/n,
18071-Granada (Spain)
crr@ugr.es

Disclosure: This study was financially supported by research group BIO277 (Junta de Andalucía) and by the Department of Nursing of the Faculty of Health Sciences, University of Granada.

References

1. Werner S, Grose R. Regulation of wound healing by growth factors and cytokines. Physiol Rev. 2003;83(3):835-870. 2. Anitua E, Andia I, Ardanza B, Nurden P, Nurden AT. Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb Haemost. 2004;91(1):4-15. 3. Stadelmann WK, Digenis AG, Tobin GR. Physiology and healing dynamics of chronic cutaneous wounds. Am J Surg. 1998;176(2A Suppl):26S-38S. 4. Greenhalgh DG. Wound healing and diabetes mellitus. Clin Plast Surg. 2003;30(1):37-45. 5. Sánchez AR, Sheridan PJ, Kupp LI. Is platelet-rich plasma the perfect enhancement factor? A current review. Int J Oral Maxillofac Implants. 2003;18(1):93-103. 6. Crovetti G, Martinelli G, Issi M, et al. Platelet gel for healing cutaneous chronic wounds. Transfus Apher Sci. 2004;30(2):145-151. 7. Lieberman JR, Daluiski A, Einhorn TA. The role of growth factors in the repair of bone. Biology and clinical applications. J Bone Joint Surg Am. 2002;84-A(6):1032-1044. 8. Chen J, Yang J, Huang W. Study on collagen membrane combinating with autogenous bone marrow stromal cells or platelet rich plasma in repairing alveolar bone defect in dogs [in Chinese]. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2007;21(5):523-527. 9. Yol S, Tekin A, Yilmaz H, et al. Effects of platelet rich plasma on colonic anastomosis. J Surg Res. 2008;146(2):190-194. 10. Yu C, Wang J, Fu Y, et al. Treatment of skin injury due to vinorelbine extravasation using bFGF and rhGM-CSF: an experimental study in a murine model. Biol Res Nurs. 2011;13(1):32-37. 11. Diegelmann RF, Evans MC. Wound healing: an overview of acute, fibrotic and delayed healing. Front Biosci. 2004;9:283-289. 12. Rendu F, Brohard-Bohn B. The platelet release reaction: granules’ constituents, secretion and functions. Platelets. 2001;12(5):261-273. 13. Rozman P, Bolta Z. Use of platelet growth factors in treating wounds and soft-tissue injuries. Acta Dermatovenerol Alp Panonica Adriat. 2007;16(4):156-165. 14. Everts PA, Brown Mahoney C, Hoffmann JJ, et al. Platelet-rich plasma preparation using three devices: implications for platelet activation and platelet growth factor release. Growth Factors. 2006;24(3):165-171. 15. Anitua E. The use of plasma-rich growth factors (PRGF) in oral surgery. Pract Proced Aesthet Dent. 2001;13(6):487-493. 16. Mishra A, Woodall J Jr, Vieira A. Treatment of tendon and muscle using platelet-rich plasma. Clin Sports Med. 2009;28(1):113-125. 17. Marx RE. Platelet-rich plasma (PRP): what is PRP and what is not PRP? Implant Dent. 2001;10(4):225-228. 18. Knighton DR, Hunt TK, Thakral KK, Goodson WH 3rd. Role of platelets and fibrin in the healing sequence: an in vivo study of angiogenesis and collagen synthesis. Ann Surg. 1982;196(4):379-388. 19. Antoniades HN, Williams LT. Human platelet-derived growth factor: structure and function. Fed Proc. 1983;42(9):2630-2634. 20. Ross R, Raines EW, Bowen-Pope DF. The biology of platelet-derived growth factor. Cell. 1986;46(2):155-169. 21. Bowen-Pope DF, van Koppen A, Schatteman G. Is PDGF really important? Testing the hypotheses. Trends Genet. 1991;7(11-12):413-418. 22. Shih SD, Rees TD, Miller EG, Wright JM, Iacopino AM. The effects of platelet-derived growth factor-BB and insulin-like growth factor-1 on epithelial dysplasia. J Periodontol. 1996;67(11):1224-1232. 23. Marx RE, Carlson ER, Eichstaedt RM, Schimmele SR, Strauss JE, Georgeff KR. Platelet-rich plasma: Growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998;85(6):638-646. 24. Anitua E. Plasma rich in growth factors: preliminary results of use in the preparation of future sites for implants. Int J Oral Maxillofac Implants. 1999;14(4):529-535. 25. Cenni E, Ciapetti G, Pagani S, Perut F, Giunti A, Baldini N. Effects of activated platelet concentrates on human primary cultures of fibroblasts and osteoblasts. J Periodontol. 2005;76(3):323-328. 26. Anitua E, Sanchez M, Nurden AT, et al. Reciprocal actions of platelet-secreted TGF-beta1 on the production of VEGF and HGF by human tendon cells. Plast Reconstr Surg. 2007;119(3):950-959. 27. Mishra A, Pavelko T. Treatment of chronic elbow tendinosis with buffered platelet-rich plasma. Am J Sports Med. 2006;34(11):1774-1778. 28. Cullinane AB, O’Callaghan P, McDermott K, Keohane C, Cleary PE. Effects of autologous platelet concentrate and serum on retinal wound healing in an animal model. Graefes Arch Clin Exp Ophthalmol. 2002;240(1):35-41. 29. Whitman DH, Berry RL, Green DM. Platelet gel: an autologous alternative to fibrin glue with applications in oral and maxillofacial surgery. J Oral Maxillofac Surg. 1997;55(11):1294-1299. 30. Lynch SE, Colvin RB, Antoniades HN. Growth factors in wound healing. Single and synergistic effects on partial thickness porcine skin wounds. J Clin Invest. 1989;84(2):640-646. 31. Rutherford RB, Niekrash CE, Kennedy JE, Charette MF. Platelet-derived and insulin-like growth factors stimulate regeneration of periodontal attachment in monkeys. J Periodont Res. 1992;27(4):285-290. 32. Rutherford RB, Ryan ME, Kennedy JE, Tucker MM, Charette MF. Platelet-derived growth factor and dexamethasone combined with a collagen matrix induce regeneration of the periodontium in monkeys. J Clin Periodontol. 1993;20(7):537-544. 33. Mancuso JD, Bennion JW, Hull MJ, Winterholler BW. Platelet-rich plasma: a preliminary report in routine impacted mandibular third molar surgery and the prevention of alveolar osteitis. J Oral Maxillofac Surg. 2003;61(8):40. 34. de Obarrio JJ, Araúz-Dutari JI, Chamberlain TM, Croston A. The use of autologous growth factors in periodontal surgical therapy: platelet gel biotechnology--case reports. Int J Periodontics Restorative Dent. 2000;20(5):486-497. 35. Garg AK. The use of platelet-rich plasma to enhance the success of bone grafts around dental implants. Dent Implantol Update. 2000;11(3):17-21. 36. Camargo PM, Lekovic V, Weinlaender M, Vasilic N, Madzarevic M, Kenney EB. Platelet-rich plasma and bovine porous bone mineral combined with guided tissue regeneration in the treatment of intrabony defects in humans. J Periodontal Res. 2002;37(4):300-306. 37. Carlson NE, Roach RB Jr. Platelet-rich plasma: clinical applications in dentistry. J Am Dent Assoc. 2002;133(10):1383-1386. 38. Kim SG, Chung CH, Kim YK, Park JC, Lim SC. Use of particulate dentin-plaster of Paris combination with/without platelet-rich plasma in the treatment of bone defects around implants. Int J Oral Maxillofac Implants. 2002;17(1):86-94. 39. García-Martínez O, Reyes-Botella C, Díaz-Rodríguez L, et al. Effect of platelet-rich plasma on growth and antigenic profile of human osteoblasts and its clinical impact. J Oral Maxillofac Surg. 2012;70(7):1558-1564. 40. Bhanot S, Alex JC. Current applications of platelet gels in facial plastic surgery. Facial Plast Surg. 2002;18(1):27-33. 41. Valbonesi M, Giannini G, Migliori F, Dalla Costa R, Galli A. The role of autologous fibrin-platelet glue in plastic surgery: a preliminary report. Int J Artif Organs. 2002;25(4):334-338. 42. Man D, Plosker H, Winland-Brown JE. The use of autologous platelet-rich plasma (platelet gel) and autologous platelet-poor plasma (fibrin glue) in cosmetic surgery. Plast Reconstr Surg. 2001;107(1):229-239. 43. Schlegel KA, Kloss FR, Schultze-Mosgau S, Neukam FW, Wiltfang J. Osseous defect regeneration using autogenous bone alone or combined with Biogran or Algipore with and without added thrombocytes. A microradiologic evaluation [in German]. Mund Kiefer Gesichtschir. 2003;7(2):112-118. 44. Roldán JC, Jepsen S, Miller J, et al. Bone formation in the presence of platelet-rich plasma vs. bone morphogenetic protein-7. Bone. 2004;34(1):80-90. 45. Wiltfang J, Kloss FR, Kessler P, et al. Effects of platelet-rich plasma on bone healing in combination with autogenous bone and bone substitutes in critical-size defects. An animal experiment. Clin Oral Implants Res. 2004;15(2):187-193. 46. Choi BH, Zhu SJ, Kim BY, Huh JY, Lee SH, Jung JH. Effect of platelet-rich plasma (PRP) concentration on the viability and proliferation of alveolar bone cells: an in vitro study. Int J Oral Maxillofac Surg. 2005;34(4):420-424. 47. Gruber R, Varga F, Fischer MB, Watzek G. Platelets stimulate proliferation of bone cells: involvement of platelet-derived growth factor, microparticles and membranes. Clin Oral Implants Res. 2002;13(5):529-535. 48. Graziani F, Cei S, Ducci F, Giuca MR, Donos N, Gabriele M. In vitro effects of different concentration of PRP on primary bone and gingival cell lines. Preliminary results. Minerva Stomatol. 2005;54(1-2):15-22. 49. Woodall J Jr, Tucci M, Mishra A, Benghuzzi H. Cellular effects of platelet rich plasma: a study on HL-60 macrophage-like cells. Biomed Sci Instrum. 2007;43:266-271. 50. Anitua E, Andía I, Sanchez M, et al. Autologous preparations rich in growth factors promote proliferation and induce VEGF and HGF production by human tendon cells in culture. J Orthop Res. 2005;23(2):281-286. 51. Sánchez AR, Sheridan PJ, Eckert SE, Weaver AL. Regenerative potential of platelet-rich plasma added to xenogenic bone grafts in peri-implant defects: a histomorphometric analysis in dogs. J Periodontol. 2005;76(10):1637-1644. 52. Sánchez M, Anitua E, Azofra J, Andía I, Padilla S, Mujika I. Comparison of surgically repaired Achilles tendon tears using platelet-rich fibrin matrices. Am J Sports Med. 2007;35(2):245-251. 53. Paques M, Chastang C, Mathis A, et al. Effect of autologous platelet concentrate in surgery for idiopathic macular hole: results of a multicenter, double-masked, randomized trial. Platelets in Macular Hole Surgery Group. Ophthalmology. 1999;106(5):932-938. 54. Farrag TY, Lehar M, Verhaegen P, Carson KA, Byrne PJ. Effect of platelet rich plasma and fibrin sealant on facial nerve regeneration in a rat model. Laryngoscope. 2007;117(1):157-165. 55. Wallace JL, Dicay M, McKnight W, Dudar GK. Platelets accelerate gastric ulcer healing through presentation of vascular endothelial growth factor. Br J Pharmacol. 2006;148(3):274-278. 56. Atri SC, Misra J, Bisht D, Misra K. Use of homologous platelet factors in achieving total healing of recalcitrant skin ulcers. Surgery. 1990;108(3):508-512. 57. Knighton DR, Doucette M, Fiegel VD, Ciresi K, Butler E, Austin L. The use of platelet derived wound healing formula in human clinical trials. Prog Clin Biol Res. 1988;266:319-329. 58. Krupski WC, Reilly LM, Perez S, Moss KM, Crombleholme PA, Rapp JH. A prospective randomized trial of autologous platelet-derived wound healing factors for treatment of chronic nonhealing wounds: a preliminary report. J Vasc Surg. 1991;14(4):526-536. 59. Stacey MC, Mata SD, Trengove NJ, Mather CA. Randomised double-blind placebo controlled trial of topical autologous platelet lysate in venous ulcer healing. Eur J Vasc Endovasc Surg. 2000;20(3):296-301. 60. Anitua E, Aguirre JJ, Algorta J, et al. Effectiveness of autologous preparation rich in growth factors for the treatment of chronic cutaneous ulcers. J Biomed Mater Res B Appl Biomater. 2008;84(2):415-421. 61. Tarroni G, Tessarin C, De Silvestro L, et al. Local therapy with platelet-derived growth factors for chronic diabetic ulcers in haemodialysis patients [in Italian]. G Ital Nefrol. 2002;19(6):630-633. 62. Herouy Y, Mellios P, Bandemir E, et al. Autologous platelet-derived wound healing factor promotes angiogenesis via alphavbeta3-integrin expression in chronic wounds. Int J Mol Med. 2000;6(5):515-519. 63. Ramos-Torrecillas J, De Luna-Bertos E, García-Martínez O, Díaz-Rodríguez L, Ruiz C. Use of platelet-rich plasma to treat pressure ulcers: a case study. J Wound Ostomy Continence Nurs. 2013;40(2):198-202. 64. Anitua E, Sánchez M, Nurden AT, Nurden P, Orive G, Andía I. New insights into and novel applications for platelet-rich fibrin therapies. Trends Biotechnol. 2006;24(5):227-234. 65. Stelnicki EJ, Longaker MT, Holmes D, et al. Bone morphogenetic protein-2 induces scar formation and skin maturation in the second trimester fetus. Plast Reconstr Surg. 1998;101(1):12-19. 66. Cheung E, Katti D, Rosier R, Laurencin C. Review of state of the art: Growth factor-based system for use as bone graft substitutes. In: Laurencin CT, ed. Bone Graft Substitutes. West Conshohocken, PA: ASTM International; 2003:174-88. 67. Gale NW, Yancopoulos GD. Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development. Genes Dev. 1999;13(9):1055-1066. 68. Moore KW, de Waal Malefyt R, Coffman RL, O’Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol. 2001;19:683-765.